Medical Breakthroughs

CMS Compliance for AI UM: What Investors Need to See

Listen to this article · 7 min listen

The idea of AI-powered automated prior authorization gets the attention of any payer compliance officer or utilization management leader. It promises efficiency, lower costs, and better care coordination. But when a vendor’s launch announcement leads with a big “CMS compliance” claim for its AI platform, you have to ask a simple question: where’s the proof? This isn’t about processing speed. It’s about submission accuracy, a metric that demands real scrutiny, especially with how fast healthcare AI regulations are changing.

The Innovaccer Galaxy UM Launch and its CMS Compliance Claim

So Innovaccer recently announced its Galaxy UM platform, an AI for utilization management, saying right out of the gate that it “automates prior authorizations while ensuring CMS compliance” Innovaccer Galaxy UM launch announcement. That’s their own language. They’re making CMS compliance a main selling point, a core feature. If you’re a payer compliance officer, that’s a huge assertion, because any automated PA decision will be judged by how accurately it submits and validates information against regulatory requirements. The pitch is that this thing simplifies your life and guarantees you’re following every complex, constantly-changing rule from the Centers for Medicare & Medicaid Services (CMS). But here’s the catch. While Innovaccer says the platform is HIPAA compliant, HITRUST certified, and has its SOC 2 Type II, if you look at the public launch materials for Galaxy UM, you won’t find a single number proving prior authorization submission accuracy. No submission accuracy percentages, no audit results, no error rates tied to the AI’s PA decisions. So without that specific, measurable data, what does “ensuring CMS compliance” actually mean for an AI system, and how is a payer supposed to verify that claim beyond the marketing copy?

The Regulatory Submission Accuracy Bar Set by Imaging AI

If you want to know what a real CMS compliance claim for a UM AI should look like, just look at the precedent from the imaging AI sector. Companies like Viz.ai have already set a high bar where “Regulatory Submission Accuracy” is a well-understood and recorded metric. In that space, the AI is expected to produce outputs that are demonstrably correct the first time. For imaging AI, this means things like clinical validation studies, actual FDA clearances (like a 510(k) or De Novo Classification), and a clear, public understanding of the AI’s performance inside a regulated system FDA guidance on AI/ML medical devices. Automated PA offers speed, sure, but the regulatory standard is all about precision, especially when patient care and payer money are on the line. An AI platform must be able to generate PA requests or decisions that are “right the first time.” It has to correctly interpret clinical criteria, apply the right payer policies, and produce a submission that will survive an audit, not just fill out a form faster.

What the Galaxy UM Launch Claim Must Show for Checkable Compliance

Innovaccer’s claim that Galaxy UM “ensures CMS compliance” is, at its heart, a submission accuracy claim. For that to be a checkable fact instead of just marketing fluff, the vendor needs to show its work. You’d need to see independent validation of its accuracy in applying CMS guidelines and specific payer policies, probably through retrospective studies that compare the AI’s PA decisions against human expert reviews with clear metrics on agreement rates. And where are the published audit results? Payer compliance officers live and die by audits, so an AI platform claiming compliance should have its own internal or external audit history showing how it finds, fixes, and prevents errors. Finally, they need to be transparent about error rates. No AI is perfect (far from it), so admitting and quantifying errors, and having a clear plan for continuous improvement and mitigating algorithmic drift, is how you build trust. This is just basic Good Machine Learning Practice (GMLP) GMLP principles for AI in healthcare. Without this kind of evidence, the “ensuring CMS compliance” claim is just an aspiration, not a verifiable fact. The imaging AI sector’s focus on Regulatory Submission Accuracy gives us a solid benchmark for what “compliance” means in the real world.

What a Careful Buyer Should Demand as Evidence

If you’re a compliance officer or a UM leader looking at a tool like Innovaccer’s Galaxy UM, the fact that the launch materials are missing hard data on submission accuracy, audits, or error rates should give you pause. It’s a red flag. The bottom line is this: a vendor’s “CMS compliance” claim is just marketing noise unless they can back it up with the kind of regulatory submission accuracy numbers that the imaging AI world has already established as the standard. That’s what makes the claim measurable. So, a smart buyer has to demand proof. Here’s your list of demands:

  • Submission Accuracy Data: Show me the numbers. I need quantifiable data on the platform’s accuracy for generating compliant PA submissions, like first-pass approval rates or how much it reduced denials from bad paperwork.
  • Audit Trails and Explainability: I need to see the receipts. Give me detailed audit trails showing exactly how the AI made a decision, so a human can review it. Explainability is everything for compliance and for handling appeals.
  • Error Rate Transparency and Mitigation Strategies: Be honest about the error rates. I want clear reports on errors and to see the system you have for catching, fixing, and learning from them. This must include a plan for monitoring algorithmic drift as rules change.
  • Independent Third-Party Validation: Don’t just take your word for it. I want to see reports from independent third parties, like HITRUST or SOC 2 Type II, that certify the platform’s compliance and data security claims HITRUST Alliance website.
  • Commitment to Regulatory Updates: What’s the plan for the future? Show me a clear roadmap for how the platform will keep up with new CMS guidance, changes in payer policies, and whatever new AI regulations come down the pike.

Look, moving to automated prior authorization is a massive opportunity for payers, but we can’t throw regulatory integrity out the window to get there. The burden of proof for any “CMS compliance” claim is 100% on the AI vendor. Until they can show specific, measurable evidence of submission accuracy, any promise of “ensuring CMS compliance” is just a talking point that needs to be met with some serious questions from anyone whose job is to protect payer operations and patient care.

Frequently Asked Questions

What evidence should we look for to validate an AI platform’s claim of CMS compliance for prior authorization?

To validate a claim of CMS compliance, look for specific, measurable evidence such as prior authorization submission accuracy percentages, audit results, and error rates directly related to the AI’s prior authorization decisions. This moves beyond promotional language to verifiable compliance. The imaging AI sector sets a precedent for this by emphasizing ‘Regulatory Submission Accuracy’ through clinical validation studies and FDA clearances.

How does ‘submission accuracy’ relate to CMS compliance for AI-powered prior authorization?

Submission accuracy is fundamental to CMS compliance for AI-powered prior authorization. It means the AI platform’s outputs are demonstrably correct the first time, accurately interpreting clinical criteria, applying payer policies, and generating submissions that withstand audit. Without transparent data on submission accuracy, a claim of ‘ensuring CMS compliance’ remains aspirational rather than verifiable.

What specific types of data or studies should a vendor provide to demonstrate an AI platform’s compliance with CMS regulations?

A vendor should provide independent validation of the AI’s accuracy in applying CMS guidelines and payer-specific policies, potentially through prospective or retrospective studies comparing AI decisions against human expert review. They should also offer published audit results detailing error identification and rectification, and transparently disclose quantified error rates with a strategy for continuous improvement. This aligns with principles like Good Machine Learning Practice (GMLP).

Share
Was this article helpful?

Editorial Team

The Editorial Team at Healthcare AI Compliance Watch is a group of writers and editors who cover health, workplace wellness, and everyday care. They research each story and publish under a shared desk byline — experts in their fields, working as one team.